|
Volumn 59, Issue 1, 2013, Pages 53-60
|
Reaction of plasma adiponectin level in non-small cell lung cancer patients treated with EGFR-TKIs.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADIPONECTIN;
ADIPOQ PROTEIN, HUMAN;
ANTINEOPLASTIC AGENT;
EGFR PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
INSULIN;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
TUMOR MARKER;
AGED;
ARTICLE;
BLOOD;
DRUG ANTAGONISM;
ENZYMOLOGY;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METABOLISM;
MIDDLE AGED;
MOLECULARLY TARGETED THERAPY;
PROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
VERY ELDERLY;
ADIPONECTIN;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
HUMANS;
INSULIN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
MOLECULAR TARGETED THERAPY;
PROSPECTIVE STUDIES;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84882386029
PISSN: 00306096
EISSN: None
Source Type: None
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|